Cannabis-based Medication

Lord Dear Excerpts

Wednesday 21st February 2018 Lords Chamber

[Baroness Williams of Trafford]

My noble friend makes precisely the point that I perhaps did not make as well, which is that within the legal framework we have to explore the art of the possible to bring such drugs forward that will help people in situations similar to Alfie’s. Before I became a politician, I worked extensively with people who had multiple sclerosis, and I know that Sativex has been produced in aid of alleviating spasticity in suffers of that illness.

[Lord Dear (CB)]

My Lords, can I move away from the sad case that we have heard about and those particular circumstances and move to a more general point on that issue? Does the Minister agree that the time has now come for a complete and urgent look at the situation? As many of us know, cannabis is currently included in Schedule 1 to the Misuse of Drugs Act as a drug with no medicinal value, yet that view has been roundly rebuffed by a number of countries in the world. I cite, for example, 12 EU countries—shortly that number will grow to 15—29 states in the USA, Canada, Israel and so on, all of which use cannabis under medical supervision. Will the Minister assure the House that the Government will look at this issue and at the licensed medicinal use of cannabis in these circumstances?

[Baroness Williams of Trafford]

The noble Lord has nicely segued through the general use of it back to the medicinal use, but I concur with him in saying that we must keep laws like this under review. Certainly, the WHO is currently reviewing cannabis as a whole, and the constituent parts of cannabis. The noble Lord is right that a number of states in the USA have actually legalised its use. We are keeping a very close eye on the outcome of that review and will take a view on it in due course.